🔎 Trials Near Me

Beranda › Narkolepsi › South Carolina

Uji klinis Narkolepsi di South Carolina

7 studi untuk Narkolepsi mencari peserta di lokasi di South Carolina.

Kota di South Carolina

Teks studi resmi (Bahasa Inggris)

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Columbia, South Carolina, Columbia
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07598708

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  • Alkermes Investigational Site, Columbia
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07455383

A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)

  • Bogan Sleep Consultants, Columbia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07540364

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

  • Lowcountry Lung and Critical Care PA, Charleston
  • Medical University of South Carolina, Charleston
  • Bogan Sleep Consultants, LLC, Columbia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07675135

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  • Alkermes Investigational Site, Columbia
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06767683

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

  • Bogan Sleep Consultants, LLC, Columbia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07493265

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • North Charleston, South Carolina, North Charleston
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07096674

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.